Modern announcement that its vacancy against the South African variant of COVID-19 is listed for trial

The laboratory stadadounidense Modern informs you that its new vaccine was unveiled to combat the South African variant of COVID-19 was sent to the EEUU National Institutes of Health for testing.

“We will learn with the beginning of clinical practice” from phase 1, said the executive director of the biotechnology company, Stephane Bancel.

“While looking for weapons to destroy COVID-19, we will be vigilant and proactive in anticipating the emergence of new SARS-CoV-2 variants. Approving the flexibility of our ARNm platform, we are moving quickly to try out the updates of the vacancies that abort the emerging variants of the virus ”, añadió Bancel.

In a study published last week, Modern fashion shows that the song of the people who receive the actual vaccine possesses neutralizing antidotes against the varying principles of COVID-19. But only a sixth part of the anti-cancer protections against variant B.1.351 of the virus, which originated in South Africa and is the objective of its new vaccine.

It is not clear if this level of antiquity is sufficient to protect the people against synthetic cases or the coves of COVID-19 of this new variant.

It is because “Por precaución” -dijo the company in a press release published by mércoles- has started to work on two possible strategies against the variant: give people a dose of refueling the original car to increase the levels of anticipation, and to devalue specific cars for variants. which can be summed up in the original.

In addition, the company states that it has agreed to carry out so many updates to its vacancy as it needs to “ensure that the pandemic is under control”.

Modern, which manufactures one of the two vacancies authorized by the FDA in the EU that has produced enough of its specific vaccine against the South African variant, called mRNA-1273.351, to start testing in person.

Any change in the manufacture of vacancies, including those that are used to combat the new variants of the virus, will be approved by the Food and Drug Administration of the EU, there will be the same authorization process held for its original injections.

The National Institute of Allergy and Infectious Diseases collaborates with clinical trials to be tested if ARNm-1273.351 can increase immunization against the variant. In its announcement of the high schools, the company said that it had sent sufficient doses of this specific variant of vaccine needed for the trials.

Other car companies against COVID-19, such as Pfizer-BioNTech, Novavax, Johnson & Johnson at AstraZeneca-Oxford University, he also says that he is working on new versions of his vacancies or refunds to increase his protection.

The South African cheese is considered as one of the most fun varieties of covid-19 because log evadir some of the blocks that establish anticuerpos against the older versions of the virus.

This implies that people infected with variants previas are most susceptible to becoming a nurse and the investigations have shown that the protection of the first generation of vacancies is most reduced, even though the Mayor will be effective.

Modern also announces that it will increase its global manufacturing capacity to produce 1,400 million doses of its vaccine in 2022.

Además, dijo aumentará su manufacturing plan for 2021 from 600 million dose to 700 million. Moderna has sent 60 million doses, 55 million within the United States.

SEGUIR LEYENDO: